| (USD) | Sep 2022 | Y/Y change |
|---|---|---|
| Revenue | 8.19M | — |
| Operating expense | — | — |
| Net income | -14.21M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IDXG returned +73.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +23.8% |
| 1 year | +73.1% |
| All-time high | $3.10 (Nov 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IDXG would be worth today ›No. Interpace Biosciences, Inc. has not paid a dividend in the past 12 months.
Interpace Biosciences, Inc. is part of the Healthcare sector.
Interpace Biosciences, Inc. has a market cap of 42.19M USD, based on the latest quote.
